Next-generation Sequencing-based CE-IVD Solution Provides Accurate, Reliable, Fast and Scalable End-to-end Genome-wide Noninvasive Prenatal Testing Illumina's VeriSeq NIPT Solution v2 (Photo: Business ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO ...
On Monday, Illumina, Inc. (NASDAQ:ILMN) agreed to acquire Standard BioTools’ (NASDAQ:LAB) subsidiary, SomaLogic. Following the announcement of the acquisition, Standard BioTools’ stock experienced a ...
According to MarketsandMarkets, The report Next-generation Sequencing Services Market is projected to grow from USD 3.80 billion in 2025 and ...
Creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program Nashville Biosciences LLC (NashBio), a leading clinical and ...
MELBOURNE, Australia--(BUSINESS WIRE)--Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback